NAALAD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NAALAD monoclonal antibodies for investigating N-acetylated alpha-linked acidic dipeptidase (NAALADase) in various biological processes. NAALAD monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NAALADase is an essential enzyme that hydrolyzes N-acetylated neuropeptides, playing a fundamental role in neuropeptide signaling and modulation of synaptic transmission. In the central nervous system, NAALADase influences crucial processes such as pain perception, memory, and neuroprotection. Research focused on NAALADase activity and regulation continues to advance understanding of various neurological disorders. NAALAD monoclonal antibodies enable precise detection and characterization of NAALADase expression patterns across different tissues and experimental conditions. Studying NAALADase function has revealed promising opportunities for therapeutic intervention in neurological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of NAALADase and its impact on human health.